Role of Pharmacovigilance in Drug Development

Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problem. PV collects, records, codes ADEs/ADRs analyses and assesses the reports, promotes the safe use of drugs, creates appropriate structures and means of communication needed to perform its tasks. The aims of PV are to improve patient care and safety, improve public health and safety, contribute to the assessment of benefit, harm, effectiveness and risk of medicines, promote education and clinical training, promote effective communication to public and promote rational and safe use of medicines.

 

The process of drug discovery and development is a long-term, competitive, expensive and complicated process. Bringing the drugs from the bench to the market, that is, from screening and identification of the drug as a compound to its introduction to the market, takes several years of efforts [1].The process of discovering and developing a new drug involves an intricate interaction between investors, industry, academia, patent laws, regulatory authorities, marketing and the necessity to balance confidentiality with communication [2]. The complete process of presenting a drug to the patients involves four stages- 1. Drug discovery, 2. Drug development, 3. Regulatory review and approval, and 4. Marketing [3].

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/pharmacovigilance-and-drug-safety-open-access

Contact Us: pharmacovigilance-drugsafety@enlivenarchive.org

 

Leave a Reply

Your email address will not be published. Required fields are marked *